|Weight:||2.5 mg/5 ml|
|Therapeutic Class:||Non-sedating antihistamines|
|Manufacturer:||Drug International Ltd.|
|Last Updated:||2020-11-20 18:15:00|
Aslor Syrup contains Desloratadine. Aslor uses:
Allergic Rhinitis: Aslor Syrup is indicated for the relief of the nasal and non-nasal symptoms of allergic rhinitis (Both seasonal and perennial) in patients 2 years of age and older.
Chronic Idiopathic Urticaria: Aslor Syrup is also indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 2 years of age and older.
Aslor Syrup contains Desloratadine 2.5 mg/5 ml. Aslor doses:
Pediatric drops :
Aslor Syrup is generally well tolerated. However, dry mouth, fatigue, somnolence and myalgia are commonly reported side-effects. Less common side-effects may include dizziness, headache and nausea. Rarely rash, pruritus and urticaria may occur.
Aslor Syrup is a long-acting, tricyclic, non-sedating, selective peripheral histamine H1-receptor antagonist which inhibits the release of pro-inflammatory mediators from human mast cells and basophils.
Hepatic and renal impairment. Pregnancy and lactation.
Concomitant administration of Erythromycin, Ketoconazole, Azithromycin, Fluoxetine, and Cimetidine with Aslor Syrup increased the plasma concentration of Aslor Syrup. But there were no clinically relevant changes in the safety profile of Aslor Syrup.
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Aslor Syrup should be used in pregnancy only if clearly needed.
Lactation: Aslor Syrup passes into breast milk. Therefore, a decision should be made whether to discontinue nursing or to discontinue Aslor Syrup, taking into account the importance of the drug to the mother.
Aslor Syrup is contraindicated in patient having hypersensitivity to this medication or to any of its ingredients or Loratadine.
Paediatric Use: The safety and effectiveness of Aslor Syrup in pediatric patients under 2 years of age have not been established.
Geriatric Use: In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
In adult patients with liver or renal impairment: A starting dose of one 5 mg tablet every other day is recommended based on pharmacokinetic data.
No clinically relevant adverse events have been reported in case of overdosage. However, in the event of overdosage, symptomatic and supportive treatment is recommended.
Store in a cool and dry place, protected from light.
Aslor Syrup price in Bangladesh 43.54